FREEMAN KEVIN D bought GALT
July 17, 2025 · Form 4 insider transaction
FREEMAN KEVIN D bought 5,000 shares of Galectin Therapeutics Inc. at $2.90 per share, a transaction worth $14.5K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
5,000
Price
$2.90
Total value
$14.5K
InsiderFREEMAN KEVIN D
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateJuly 17, 2025
Filing dateJuly 18, 2025
Shares owned after49,769
OwnershipDirect
10b5-1 planNo
AmendedNo